Am J Gastroenterol

1. LEE D, Maravic Z, Moon AM, Langenbacher D, et al
   Enhancing Patient Empowerment Through Artificial Intelligence in Liver Cancer.
   Am J Gastroenterol. 2026;121:847-854.
   

   >> Share

   
   

   
   Anticancer Res

2. KATAYAMA R, Aoki T, Tashiro Y, Hirai T, et al
   Relationship Between Histopathological Growth Patterns and Indocyanine Green Fluorescence in Colorectal Liver Metastases.
   Anticancer Res. 2026;46:2087-2093.
   

   >> Share

   
   
3. SHIMOHIGASHI Y, Toya R, Kai Y, Doi Y, et al
   Whole-liver Palliative Radiotherapy Using SIB for Diffuse Liver Metastases: 3D-CRT versus (99m)Tc-GSA SPECT Image-guided VMAT.
   Anticancer Res. 2026;46:2277-2284.
   

   >> Share

   
   
4. HOSHIAI S, Yamada T, Kobayashi M, Amano T, et al
   Balloon-occluded Infusion of Fragmented Gelatin Particles of Transarterial Embolization for Hypervascular Hepatic Metastases: A Prospective Trial.
   Anticancer Res. 2026;46:2053-2062.
   

   >> Share

   
   
5. ZHOU Y, Nakamura M, Makita K, Hiroshima Y, et al
   Clinical Outcomes of Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract.
   Anticancer Res. 2026;46:2175-2185.
   

   >> Share

   
   

   
   BMC Cancer

6. JIANG HH, Feng GY, Shi Y, Li XD, et al
   Chemoresistance and genetic mutations in hepatocellular carcinoma: a pharmacogenomic atlas of 51 patients.
   BMC Cancer. 2026 Mar 28. doi: 10.1186/s12885-026-15621.
   

   >> Share

   
   
7. ZHAO YM, Xie SS, Yu YQ, Li ZX, et al
   A web-based prognostic nomogram incorporating VETC-associated imaging markers for predicting postoperative recurrence in hepatocellular carcinoma.
   BMC Cancer. 2026 Mar 28. doi: 10.1186/s12885-026-15895.
   

   >> Share

   
   
8. WANG X, Jiang Q, Chen S, Li Y, et al
   Efficacy and safety of Y90 radioembolization combined with targeted therapy and immunotherapy in patients with unresectable hepatocellular carcinoma: a dual-center, retrospective study.
   BMC Cancer. 2026 Apr 1. doi: 10.1186/s12885-026-15930.
   

   >> Share

   
   

   
   BMC Gastroenterol

9. IBRAHIM A, Abdelhady SA, Rageh F, Elgamal R, et al
   Vitamin D receptor gene polymorphism and its association with the susceptibility to Helicobacter pylori infection in the Egyptian population with hepatocellular carcinoma.
   BMC Gastroenterol. 2026 Apr 2. doi: 10.1186/s12876-026-04740.
   

   >> Share

   
   

   
   Cancer Res

10. GREENE E, Horvat NK, Doxie DB, Parihar VC, et al
    High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma.
    Cancer Res. 2026;86:1753-1768.
    

    >> Share

    
    

    
    Eur Radiol

11. WANG D, Lyu R, Zhang Y, Hu WJ, et al
    LI-RADS nonradiation treatment response assessment version 2024: diagnostic performance in HCC treated with transarterial chemoembolization.
    Eur Radiol. 2026;36:2823-2831.
    

    >> Share

    
    
12. PAISANT A, Roux M, Calame P, Lecharpentier A, et al
    Liver viscosity: pathological significance and interest for the assessment of MASLD severity in clinical practice.
    Eur Radiol. 2026;36:2978-2988.
    

    >> Share

    
    
13. ZHANG L, Wang L, Zhang Y, Zhang X, et al
    Fully automated multi-sequence detection and alignment of focal liver lesions in dynamic contrast-enhanced MRI.
    Eur Radiol. 2026;36:2435-2445.
    

    >> Share

    
    
14. OZAKI K, Ohtani T, Ishida S, Higuchi S, et al
    Predicting histopathological growth patterns and prognosis of colorectal liver metastases using MRI.
    Eur Radiol. 2026;36:2912-2928.
    

    >> Share

    
    
15. JEONG B, Han DH, Lee S, Yoon JK, et al
    Diagnosing HCC with conventional and late portal venous phase MRI: intraindividual comparison of MRI with extracellular contrast agent.
    Eur Radiol. 2026;36:2903-2911.
    

    >> Share

    
    

    
    Gastroenterology

16. BALAJI S, Bhat M
    Building the Human Liver in a Dish: Organoids, Assembloids and the Road to Precision Hepatology.
    Gastroenterology. 2026 Apr 1:S0016-5085(26)00310.
    

    >> Share

    
    
17. SCARALLO L, Alvisi P, Bramuzzo M, Domanico A, et al
    Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in children: a multicenter prospective study on behalf of the Porto IBD Working Group of ESPGHAN.
    Gastroenterology. 2026 Mar 16:S0016-5085(26)00232.
    

    >> Share

    
    

    
    Gastrointest Endosc

18. LI J, Wang Y, Zhou Y, Wang J, et al
    Endoscopic ultrasound mapping of the gastroepiploic vein in sinistral portal hypertension.
    Gastrointest Endosc. 2026 Apr 1:S0016-5107(26)00231.
    

    >> Share

    
    
19. BUTT MA, Mirminachi B, Cifuentes L, Hwang JH, et al
    Outcomes of Peroral Endoscopic Myotomy in Patients With Cirrhosis: A Multicenter Focused Communication.
    Gastrointest Endosc. 2026 Mar 26:S0016-5107(26)00217.
    

    >> Share

    
    

    
    Gut

20. CHEN Y, Dong B, Jin X, Liu C, et al
    Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes.
    Gut. 2026;75:576-587.
    

    >> Share

    
    
21. JIAO J, Song L, Xu S, Xue Y, et al
    Selenoprotein P deficiency drives hepatocellular carcinoma progression via induction of neutrophil senescence and immunosuppressive microenvironment.
    Gut. 2026 Apr 1:gutjnl-2025-336422. doi: 10.1136/gutjnl-2025-336422.
    

    >> Share

    
    

    
    Hepatology

22. SANYAL AJ, Abdelmalek MF, Loomba R
    Noninvasive surrogate endpoints of adverse outcomes, disease progression, and treatment efficacy in Metabolic Dysfunction-Associated Steatohepatitis (MASH).
    Hepatology. 2026 Mar 30. doi: 10.1097/HEP.0000000000001734.
    

    >> Share

    
    
23. PILAR BALLESTER M, Carbonell-Asins JA, Elshabrawi A, Rubin D, et al
    A randomized, open-label, Phase 2a study to assess the safety, pharmacodynamics, and pharmacokinetics of YAQ007 versus rifaximin in cirrhosis.
    Hepatology. 2026 Apr 3. doi: 10.1097/HEP.0000000000001748.
    

    >> Share

    
    

    
    Indian J Gastroenterol

24. KUMAR K, Vaithiyam V, Sonika U, Srivastava S, et al
    Bleeding ectopic varices at hepaticojejunostomy.
    Indian J Gastroenterol. 2026 Mar 28. doi: 10.1007/s12664-026-01997.
    

    >> Share

    
    

    
    J Gastroenterol

25. KUMADA T, Toyoda H, Ogawa S, Gotoh T, et al
    Comparative diagnostic performance of ultrasound-guided attenuation parameter versus B-mode scoring for hepatic steatosis assessment: an ordinal-scale statistical approach.
    J Gastroenterol. 2026 Apr 2. doi: 10.1007/s00535-026-02403.
    

    >> Share

    
    
26. REN X, Yan C, Liu X, Jia X, et al
    Bifidobacterium bifidum CIP-01 attenuates metabolic dysfunction-associated steatotic liver disease induced by high-alcohol-producing Klebsiella pneumoniae.
    J Gastroenterol. 2026;61:462-476.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

27. JINATO T, Sikaroodia M, Gilleveta PM, Dissayabutra T, et al
    Gut Microbiome Signatures Differ in Cirrhosis With and Without Hepatocellular Carcinoma in a Southeast Asian Cohort.
    J Gastroenterol Hepatol. 2026 Mar 30. doi: 10.1111/jgh.70358.
    

    >> Share

    
    

    
    J Hepatol

28. ZENG J, Gao Z, Jiang Y, Dai Z, et al
    Early Abstinence, Socioeconomic Barriers, and Survival in Decompensated Alcohol-Related Cirrhosis: A Real-World Cohort from China.
    J Hepatol. 2026 Mar 26:S0168-8278(26)00153-4. doi: 10.1016/j.jhep.2026.
    

    >> Share

    
    
29. LI S, Tong G, Xue M, Shen L, et al
    Activated hepatic stellate cells maintain liver bile acid homeostasis through paracrine FGF10/FGFR2 signaling.
    J Hepatol. 2026 Mar 26:S0168-8278(26)00149-2. doi: 10.1016/j.jhep.2026.
    

    >> Share

    
    
30. ZEEVI TT, Mezzacappa CC
    Artificial intelligence uncovers latent signals of portal hypertension in routine CT imaging.
    J Hepatol. 2026 Apr 1:S0168-8278(26)00187-X. doi: 10.1016/j.jhep.2026.
    

    >> Share

    
    

    
    N Engl J Med

31. KUMAR T, Noda SM
    Hepatic Arterial Buffer Response.
    N Engl J Med. 2026;394:1325.
    

    >> Share

    
    

    
    Oncogene

32. WANG M, Hong G, Zhang C, Xiao Y, et al
    CAPRIN1-mediated sequestration of NCOA4 mRNA into stress granules drives sorafenib resistance in hepatocellular carcinoma.
    Oncogene. 2026 Mar 28. doi: 10.1038/s41388-026-03750.
    

    >> Share

    
    
33. XU S, Gong R, Liu S, Wang J, et al
    Dual function of DOT1L suppresses tumor cell-intrinsic immunogenicity in hepatocellular carcinoma.
    Oncogene. 2026 Mar 31. doi: 10.1038/s41388-026-03744.
    

    >> Share

    
    

    
    PLoS One

34. DO TX, Nguyen HT, Nguyen PTL, Kieu MTT, et al
    Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country.
    PLoS One. 2026;21:e0345212.
    

    >> Share

    
    
35. TAKAGI A, Fujita A, Tokuda S, Tamura S, et al
    The ability of branched-chain amino acid-to-tyrosine ratio (BTR) to assess preoperative liver function of patients with hepatocellular carcinoma.
    PLoS One. 2026;21:e0344938.
    

    >> Share

    
    
36. NATURINDA K, Biraro IA, Mupere E, Muyunga A, et al
    Prevalence, perceptions and factors associated with non-adherence to hepatotoxicity monitoring among people living with HIV on tuberculosis preventive treatment at Mulago ISS clinic.
    PLoS One. 2026;21:e0345662.
    

    >> Share

    
    
37. BIBI A, Afandi MH, Mehmood A, Ashfaq UA, et al
    Anti-hepatocellular carcinoma activity of Jacaranda mimosifolia through experimental validation and network pharmacology.
    PLoS One. 2026;21:e0346325.
    

    >> Share

    
    
38. ZHANG X, Xu Z, You Y, Xie L, et al
    Lactobacillus casei culture supernatant ameliorates acute alcohol-induced liver injury by inhibiting cellular stress and promoting intestinal integrity in mice.
    PLoS One. 2026;21:e0344960.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

39. JUNG YJ, Kim S, Song IH, Shim JH, et al
    Prognostic Significance of Intraindividual CT and MRI LI-RADS Agreement and Discordance in Hepatocellular Carcinoma.
    Radiol Imaging Cancer. 2026;8:e250645.
    

    >> Share

    
    

    
    Radiology

40. CHO SH, Jung YJ, Hong SB, Choi SJ, et al
    Gadoxetate-enhanced MRI Transitional Phase Parenchymal Signal: Effect on Washout and LI-RADS Diagnostic Performance for Hepatocellular Carcinoma.
    Radiology. 2026;318:e252892.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share